Literature DB >> 29939769

Endobronchial Lung Volume Reduction in Severe Emphysema. Time to Translate Randomized Controlled Trial Results into Routine Clinical Practice?

Gaetan Deslee1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29939769     DOI： 10.1164/rccm.201805-0983ED

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  2 in total

1.  Update in Chronic Obstructive Pulmonary Disease 2018.

Authors:  Wassim W Labaki; Lucas M Kimmig; Gökhan M Mutlu; MeiLan K Han; Surya P Bhatt
Journal:  Am J Respir Crit Care Med       Date:  2019-06-15       Impact factor: 21.405

2.  Improving Lung Function in Severe Heterogenous Emphysema with the Spiration Valve System (EMPROVE). A Multicenter, Open-Label Randomized Controlled Clinical Trial.

Authors:  Gerard J Criner; Antoine Delage; Kirk Voelker; D Kyle Hogarth; Adnan Majid; Michael Zgoda; Donald R Lazarus; Roberto Casal; Sadia B Benzaquen; Robert C Holladay; Adam Wellikoff; Karel Calero; Mark J Rumbak; Paul R Branca; Muhanned Abu-Hijleh; Jorge M Mallea; Ravi Kalhan; Ashutosh Sachdeva; C Matthew Kinsey; Carla R Lamb; Michael F Reed; Wissam B Abouzgheib; Phillip V Kaplan; Gregory X Marrujo; David W Johnstone; Mario G Gasparri; Arturo A Meade; Christopher A Hergott; Chakravarthy Reddy; Richard A Mularski; Amy Hajari Case; Samir S Makani; Ray W Shepherd; Benson Chen; Gregory E Holt; Simon Martel
Journal:  Am J Respir Crit Care Med       Date:  2019-12-01       Impact factor: 21.405
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.